scispace - formally typeset
J

Juan Correa

Researcher at University of Santiago de Compostela

Publications -  23
Citations -  881

Juan Correa is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Dendrimer & Surface plasmon resonance. The author has an hindex of 13, co-authored 23 publications receiving 806 citations. Previous affiliations of Juan Correa include Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

A Click Approach to Unprotected Glycodendrimers

TL;DR: Click chemistry in combination with ultrafiltration has allowed the quick, efficient, and reliable multivalent conjugation of unprotected alkyne-derived carbohydrates to three generations of azido-terminated gallic acid−triethylene glycol dendrimers under aqueous conditions.
Journal ArticleDOI

"Clickable" PEG-dendritic block copolymers.

TL;DR: Three generations of azido-terminated PEG-dendritic block copolymers have been synthesized and completely characterized by NMR and MALDI-TOF and an increasingly higher compactness of the core with generation is determined by T(1) and T(2) relaxation time studies.
Journal ArticleDOI

Probing the relevance of lectin clustering for the reliable evaluation of multivalent carbohydrate recognition.

TL;DR: Experiments by Surface Plasmon Resonance (SPR) illustrate the relevance of lectin density for the reliable evaluation of binding efficiencies in surface-based multivalent carbohydrate recognition.
Journal ArticleDOI

Real-time evaluation of binding mechanisms in multivalent interactions: a surface plasmon resonance kinetic approach.

TL;DR: An original surface plasmon resonance kinetic approach is introduced to analyze multivalent interactions that has been validated with dendrimers as monodisperse multivalent analytes binding to lectin clusters and reveals the dynamic nature of the interaction and offers experimental evidence on the contribution of binding mechanisms.
Journal ArticleDOI

Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation.

TL;DR: GATG dendrimer decorated with 27 terminal morpholine groups was able to reduce beta-amyloid fibril formation, which might represent a new method to address the key pathology in Alzheimer's disease.